Telotristat Ethyl for Reducing Intraoperative Carcinoid Crisis in Patients With Neuroendocrine Tumors
NCT04672876
·
clinicaltrials.gov ↗
PHASE2
Phase
WITHDRAWN
Status
OTHER
Sponsor class
Stopped
Trial funding no longer available.
Conditions
Neuroendocrine Tumors
Interventions
DRUG:
Telotristat Ethyl Oral Tablet
Sponsor
University of Chicago